Inventor
Robert G. Kilbourn
Inventor
Houston, TX, US
Overview
Patents· 15 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes48%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations32%
Y02ATechnologies for adaptation to climate change19%
PatentTitleYear
6,350,729'Inhibition of nitric oxide-mediated hypotension and septic shock with iron-containing hemoprotein'20026,103,690'Prevention or inhibition of pathogenic syndromes caused by nitric oxide overproduction using iron-containing hemoprotein'20005,900,403'Use of iron hemoprotein for treating pathogenic syndrome caused by nitric oxide overproduction'19995,776,979'Method of use of cardiotonic drugs and inhibitors of nitric oxide synthesis to alleviate pathologic hypotension'19985,770,623'Argine antagonists for inhibition of systemic hypotension associated with nitric oxide production or endothelial derived relaxing factor'19985,674,836'Treatment of septic shock with iron-containing hemoprotein'19975,534,545'Parenteral amino acid formulations for the inhibition of systemic hypotension associated with nitric oxide production'19965,480,866'Hemoproteins for inhibition of nitric oxide-mediated hypotension and septic shock'19965,374,651'Methods and compositions for the treatment of hypotension with arginine free essential and essential amino acids and arginine derivatives'19945,334,380'Anti-endotoxin, interleukin-1 receptor antagonist and anti-tumor necrosis factor antibody with arginine-free formulations for the treatment of hypotension'19945,312,835'Use of cardiotonic drugs and inhibitors of nitric oxide synthesis to alleviate pathologic hypotension'19945,296,466'Inhibition of nitric oxide-mediated hypotension and septic shock with iron-containing hemoprotein'19945,286,739'Parenteral formulations for the inhibition of systemic hypotension associated with nitric oxide production or endothelial derived relaxing factor'19945,216,025'Nitric oxide synthesis inhibitors for potentiating the action of pressor agents in certain hypotensive patients'19935,028,627'Method of using arginine derivatives to inhibit systemic hypotension associated with nitric oxide production or endothelial derived relaxing factor'1991Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1991–2002Patents assigned to UNIV TEXAS (15)· patent assignee history
1991–1998Patents assigned to CORNELL RES FOUNDATION INC (7)· patent assignee history
1991–2002Based in Houston, TX, US· patent location history
1994–2002Patents assigned to UNIV DUKE (6)· patent assignee history
1994Patents assigned to STROHTECH INC (1)· patent assignee history
1996–2002Patents assigned to APEX BIOSCIENCE INC (5)· patent assignee history
1998Based in Naperville, IL, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| UNIV TEXAS | 15 | 1991–2002 |
| CORNELL RES FOUNDATION INC | 7 | 1991–1998 |
| UNIV DUKE | 6 | 1994–2002 |
| APEX BIOSCIENCE INC | 5 | 1996–2002 |
| STROHTECH INC | 1 | 1994 |
Locations
| Location | Patents | Span |
|---|---|---|
| Houston, Texas, US | 14 | 1991–2002 |
| Naperville, Illinois, US | 1 | 1998 |